Antibiotic Indications: Definition Of “Significant” Remains In FDA’s Hands After Vancocin Ruling
This article was originally published in The Pink Sheet Daily
Executive Summary
D.C. District Court Judge denies ViroPharma’s request for a preliminary injunction to require FDA to withdraw approval of three ANDAs, says company is unlikely to prevail in its suit challenging agency’s actions.